These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
758 related articles for article (PubMed ID: 26124261)
1. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis. Wang MB; Liu IY; Gornbein JA; Nguyen CT Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261 [TBL] [Abstract][Full Text] [Related]
2. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status. Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus genotype and oropharynx cancer survival in the United States of America. Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas. Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235 [TBL] [Abstract][Full Text] [Related]
5. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis. Sinha P; Karadaghy OA; Doering MM; Tuuli MG; Jackson RS; Haughey BH Oral Oncol; 2018 Nov; 86():121-131. PubMed ID: 30409292 [TBL] [Abstract][Full Text] [Related]
6. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy. Hu Q; Li F; Yang K PeerJ; 2024; 12():e17391. PubMed ID: 38784388 [TBL] [Abstract][Full Text] [Related]
7. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma. Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402 [TBL] [Abstract][Full Text] [Related]
8. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025 [TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus and Oropharyngeal Cancer. Tanaka TI; Alawi F Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488 [TBL] [Abstract][Full Text] [Related]
10. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Lim MY; Dahlstrom KR; Sturgis EM; Li G Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307 [TBL] [Abstract][Full Text] [Related]
12. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era. Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076 [TBL] [Abstract][Full Text] [Related]
13. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma. Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274 [TBL] [Abstract][Full Text] [Related]
15. Socioeconomic and Racial Disparities and Survival of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Rotsides JM; Oliver JR; Moses LE; Tam M; Li Z; Schreiber D; Jacobson AS; Hu KS; Givi B Otolaryngol Head Neck Surg; 2021 Jan; 164(1):131-138. PubMed ID: 32660368 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338 [TBL] [Abstract][Full Text] [Related]